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To the Editor: 
 Persistent and delayed healing of fistulae and local infection in previously-
irradiated areas can increase the risk of systemic complications, and complicated 
clinical management. Cancer patients have an impaired immune system secondary to 
the tumour or to the oncology treatments which decrease spontaneous healing. Surgical 
options are often associated with adverse side effects together with an increased risk of 
further delay in wound healing. Hyperbaric chambers have been used to treat delayed 
wound healing as well as several radiation-induced side effects (1). However, this 
technique is cumbersome, and with limited accessibility. Additionally, treatment and 
assessment of radiation-induced subcutaneous-fibrosis has had limited success. We 
describe, here, a case of a persistent fistula in a previously-irradiated area which was 
refractory to treatment but which was successfully treated with local ozone applications. 
The potential role of spectroscopy analysis imaging for objective assessment of 
subcutaneous-fibrosis was demonstrated. 
 
Case: 
 A 46-year-old woman was admitted to our Hospital for evaluation of a persistent 
fistula and leakage secondary to a portacath inserted in a previously-irradiated area. She 
was diagnosed 3 years earlier with right-sided, locally-advanced, breast carcinoma 
(infiltrating ductal carcinoma, T4bN1M0 Stage). She was treated with systemic 
chemotherapy (fluorouracil, epirubicin, cyclophosphamide and docetaxel). The tumour 
decrease was >50% (partial response). She underwent modified radical mastectomy 
followed by radiotherapy: 54 Gy at 2Gy/day on chest wall, axilar, supra- and infra-
clavicular areas. Radiotherapy was well tolerated, with some areas of dermatitis G-II. 
She proceeded on to hormonal therapy with tamoxifen. Local recurrence occurred in 
chest wall 2 years after the initial diagnosis. A portacath for chemotherapy 
administration was inserted in the right infra-clavicular area, which had received the 
radiotherapy. Since then, the patient presented persistent subcutaneous peri-catheter 
fistulae with continuous leakage, intermittently purulent. The catheter was removed 5 
months later when second-line chemotherapy was concluded (13 cycles of paclitaxel, 
gemcitabine and bevacizumab). Fistula and leakage continued uninterrupted over all of 
this period and persisted even after the portacath had been removed and several specific 
antibiotics administered. The patient reported progressive subcutaneous-fibrosis and 
decrease in her quality-of-life secondary to these persistent symptoms, as well as 
moderate persistent local pain. She was admitted to our hospital for evaluation of 
specific treatment four months after the catheter removal (9 months after the fistula was 
noticeable with its accompanying leakage). 
 Pre-treatment physical examination revealed a hyperpigmented fibrosis-plaque 
in the right infra-clavicular area, in the catheter-bed. Palpable subcutaneous-induration 
measured 20 x 15 mm with a fistulous cavity of 2 mm diameter and 25 mm depth. 
Leakage persisted and needed to be swabbed several times per day, every day (Fig. 1 
Left, Upper). 
 Informed consent was obtained before the commencement of treatment. Ozone 
therapy was by insufflations of O3/O2 gas mixture (100 g/ml) through the fistulous 
cavity and multiple, 4-6 infiltrations, distributed around the fibrous-induration (6-10 ml 
of O3/O2 gas mixture at 14 g/ml in each infiltration point). Ozone sessions included 15 
minutes of soft-vacuum on the fibrosis-area.  
 Spectroscopy analysis was performed using a tissue viability imaging system 
(TiVi) (TiVi600, Wheels Bridge AB, Linköping, Sweden). It is based on linearly 
polarised white light which is partly reflected by the upper layer of the skin and partly 
diffusely scattered in the deeper dermal layers. This technique generates an image 
which depends on red blood cell content in the dermal micro-vascular bed (depth of 
sampling is about 400-500 μm) (2). The TiVi device takes a standard photograph and 
automatically performs a reproducible assessment according the signal-properties 
analysed. TiVi imaging was performed pre- and post-treatment with ozone. 
 After 2 ozone-insufflation treatments over 2 weeks the fistulous cavity closed 
partially and leakage became intermittent. Follow-up treatment was subcutaneous 
infiltration in the area of fibrosis alone. After the 5
th
 session at the end of 5 weeks, the 
leakage disappeared and the fistulous cavity closed completely. The 6 initial sessions 
were 1/week. The patient was living in another of the Canary Islands and to save 
travelling and since there was clear objective improvement, the 7
th
 session was 2 weeks 
later, and the 8
th
 session was 1 month later. Hence, after 8 ozone sessions over 12 weeks 
the treatment was concluded. Local pain and symptoms had noticeably decreased by the 
end of ozone therapy, and subcutaneous-induration was lower (10 x 15 mm) and more 
superficial than initially (Fig. 1 Left, Lower).  
 Objective quantification using TiVi imaging pre- and post-treatment showed a 
measurable decrease in blood-flow stasis in the fibrosis-area (from 255+5 to 215+36 
TiVi units, 19%; p <0.001) i.e. blood flow in the skin in the fibrosis-area was more 
similar to blood flow in skin areas without fibrosis. There was a similar decrease in the 
area of the fistulous cavity (from 335+56 to 273+37 TiVi units; p <0.001). (Fig. 1 Right, 
Upper and Lower). 
 Comment 
 Subcutaneous portacath is widely used to facilitate chemotherapy 
administration. Anatomically, the placement is technically easier and with lower risk in 
the right rather than left infra-clavicular area. However, irradiated areas have an 
increased risk of delayed healing and morbidity following local invasive procedures. 
Often, it is not necessary to administer special pharmacotherapeutic agents but, 
occasionally, delayed healing can be persistent and debilitating. As with other refractory 
radiation-related side effects, the most used non-surgical approach is treatment with 
hyperbaric chambers (1). However the accessibility of the equipment is limited, and 
unavailable in our centre. The surgical approach for this problem should include block-
resection of the fibrotic area within the widely irradiated area. Often the consequence is 
increased morbidity and potential risk of further delay in wound healing. 
 Our patient was referred to our Hospital for ozone therapy because of our 
previous experience treating side effects of oncology therapy (3,4). We have described 
the effect of this technique in improving blood flow (4,5) and tissue oxygenation (6); 
both of which are decreased in radiation-induced fibrosis. Additionally, the 
antimicrobial properties of ozone augur well for complementary management of the 
documented infection associated with drained fluid (7,8). Based on the mechanism of 
action of different treatments proposed for radiation-related fistula/fibrosis (9), other 
properties ascribed to ozone therapy can be of additional clinical value as: 
immunemodulation (8), anti-inflammatory effects through phospholipase A2 decrease 
(10) and enhanced antioxidant system (8,10).  
 In our patient, physical examination (palpation) showed a decrease in the 
surface-dimension of fibrosis and level of induration. However, these assessments often 
seem imprecise and subjective. TiVi (Fig. 1 Right, Upper and Lower) is non-invasive 
and highly reproducible. In our patient, changes measured with this technique pre- and 
post-ozone treatment provided more objective assessment of the changes than palpation 
i.e. decrease in thickness and dimensions of the induration/fibrosis area. 
 In conclusion, management of refractory fistulae and fibrosis in previously-
irradiated areas can be difficult. Local treatment with ozone can be easy and effective 
especially when more standard treatments are unsuccessful, or are not available. Tissue 
viability imaging using linearly polarised light can be a very useful tool for objective 
assessment and follow-up of fibrosis.  
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Figure 1  
Details of photograph (Left) and objective quantification simultaneously obtained by 
spectroscopy analysis using linearly polarised light (Right). Red colour shows areas 
with higher red cell content in the dermal micro-vascular bed, in this case related with 
blood-flow stasis in the fibrosis-area. Upper: Before ozone therapy. Lower: After Ozone 
therapy. 
 
 
